CDKN1C anticorps (full length)

N° du produit ABIN7878078

L’anticorps anti-CDKN1C Monoclonal Souris est utilisé pour la détection de CDKN1C dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour CDKN1C anticorps (full length) (ABIN7878078)

Antigène: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CDKN1C est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: KIP2-7186

Détail du produit anti-CDKN1C anticorps

Épitope: full length

Fonction: p57Kip2 Antibody / p57 (azide and preservative free)

Purification: Protein A/G affinity

Immunogène: Recombinant full-length human p57Kip2 protein was used as the immunogen for the p57Kip2 antibody.

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal dilution of the p57Kip2 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the p57Kip2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur CDKN1C

Antigène: CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))

Autre désignation: p57Kip2

Sujet: Recognizes a protein of 57 kDa, identified as p57Kip2. It shows no cross-reaction with p27Kip1. p57Kip2 is a potent tight-binding inhibitor of several G1 cyclin complexes, and is a negative regulator of cell proliferation. Anti-p57 has been used as an aide in identification of complete hydatidiform mole (CHM) (no nuclear labeling of cytotrophoblasts and stromal cells) from partial hydatidiform mole (PHM) in which both cytotrophoblasts and stromal cells stain. The histological differentiation of complete mole, partial mole, and hydropic spontaneous abortion is problematic. Most complete hydatidiform moles are diploid, whereas most partial moles are triploid. Ploidy studies will identify partial moles, but will not differentiate complete moles from non-molar gestations. Complete moles carry a high risk of persistent disease and choriocarcinoma, while partial moles have a very low risk. In normal placenta, many cytotrophoblast nuclei and stromal cells are labeled with this antibody. Similar findings apply to PHM and hydropic abortus tissues. Intervillous trophoblastic islands (IVTIs) demonstrate nuclear labeling in all three entities and serve as an internal control.

UniProt: P49918

Pathways: Cycle Cellulaire, Dopaminergic Neurogenesis